Cramer's 'Mad Money' Recap: Just Do It Like Nike

When Cramer asked the COO what will keep Celgene's momentum going years from now, Hugin said that Revlimid is the first of Celgene's new class of oral cancer drugs called IMiDs.

Further, he said the company has two more IMiDs in the clinic already, and hopefully it will have a third soon.

Even though there are many people betting against Celgene, Cramer said he believes these people are wrong.

To view Cramer's interview with Robert Hugin, please click here.

In his Q&A session, Cramer told a student he went to law school because he initially wanted to become a prosecutor. But getting hired at Goldman Sachs is how Cramer got his financial career started.

Responding to another student, Cramer admitted that his call on Coldwater Creek (CWTR) call was indeed a bad onel.

However, Cramer wants people to understand what he did wrong. He believed that Coldwater was a regional-to-national story that wouldn't lose pizzazz, and also, he believed in the management too much -- the reasons he got burned.

But in the end, even though he said it would be easier to blame management, Cramer blamed himself only.

Lightning Round

Cramer was bullish on Dick's Sporting Goods (DKS), Diageo (DEO), Northrop Grumman (NOC), Lockheed Martin (LMT), General Dynamics (GD), Goldman Sachs (GS), Six Flags (SIX), Hanesbrands (HBI), Lowe's (LOW), Exxon Mobil (XOM), Devon Energy (DVN) and Chevron (CVX).

Cramer was bearish on Cabela's (CAB), Home Depot (HD) and Chiquita Brands (CQB).

For more of Cramer's insights during the Lightning Round, click here.

---

Want more Cramer? Check out Jim's rules and commandments for investing from his popular book by clicking here.

>To order reprints of this article, click here: Reprints